{
  "data": {
    "asOf": "2026-10-30T22:25:00.171Z",
    "dedupMethod": "exact cross-registry identifier matching; probabilistic = review only",
    "byRegistry": {
      "clinicaltrials_gov": 1
    },
    "canonicalTrial": {
      "canonicalId": "NCT07897409",
      "title": "The Impact of Using Nicorandil for the Prevention of Doxorubicin-Induced Cardiotoxicity",
      "scientificTitle": "The Impact of Using Nicorandil for the Prevention of Doxorubicin-Induced Cardiotoxicity, Including Quality of Life and Cost Analysis Among Breast Cancer Patients at Breast Cancer Hospital: A Randomized Controlled Trial in Egypt",
      "status": "not_yet_recruiting",
      "studyType": "interventional",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Doxorubicin Induced Cardiotoxicity",
        "Doxorubicin Induced Cardiomyopathy",
        "Doxorubicin",
        "Doxorubicin Adverse Reaction"
      ],
      "interventions": [
        {
          "name": "Nicorandil Oral Tablet",
          "type": "DRUG",
          "description": "drug"
        },
        {
          "name": "Adriamycin (Doxorubicin)",
          "type": "DRUG",
          "description": "AC regimen (doxorubicin 60 mg/m2 intravenous every 21 days, cyclophosphamide 600 mg/m2 intravenous every 21 days for 4 cycles)."
        }
      ],
      "sponsor": {
        "name": "Universiti Sains Malaysia",
        "type": "OTHER"
      },
      "locations": [
        {
          "city": "Cairo",
          "country": "Egypt",
          "facility": "National Cancer Institute"
        }
      ],
      "outcomes": {
        "other": [],
        "primary": [
          "To evaluate the effect of nicorandil on left ventricular ejection fraction in breast cancer patients receiving doxorubicin.",
          "To evaluate the safety of nicorandil"
        ],
        "secondary": [
          "To assess patients' quality of life",
          "To determine the effect of nicorandil on global longitudinal strain in breast cancer patients receiving doxorubicin.",
          "To evaluate the cost-utility of nicorandil as a cardioprotective agent against doxorubicin-induced cardiotoxicity.",
          "To assess the effect of nicorandil on cardiac biomarkers"
        ]
      },
      "eligibility": {
        "sex": "FEMALE",
        "criteria": "Inclusion criteria\n\n* 18 years - 65 years\n* Female patients with stage (I, II, III) breast cancer.\n* Left ventricular ejection fraction (LVEF) ≥ 55% upon breast cancer diagnosis.\n* Systolic blood pressure ≥ 90 mmHg\n* Estimated glomerular filtration rate (eGFR ≥ 60 mL/min per 1.73 m²). Exclusion criteria\n* Pregnant and lactating mothers.\n* Metastatic breast cancer. (stage IV).\n* Patients are currently using beta-blockers and phosphodiesterase 5 inhibitors.\n* Patients who require chronic use of aspirin or chronic use of corticosteroids (≥3 months).\n* Patients who are diagnosed with heart failure, myocardial infarction, stable angina, cardiogenic shock, hypovolemia, or previous coronary revascularization.\n* Previously treated with anthracyclines.\n* Previous gastrointestinal bleeding, ulcer, or perforation.\n* Severe hepatic impairment (ALT, AST ≥ 5 upper limit normal), or diagnosed with clinical evidence of hepatic ascites, encephalopathy, variceal bleeding, decompensated cirrhosis, and acute hepatitis.",
        "maximumAge": "65 Years",
        "minimumAge": "18 Years",
        "healthyVolunteers": false
      },
      "enrollment": {
        "type": "ESTIMATED",
        "count": 146
      },
      "startDate": "2026-10-01",
      "completionDate": "2027-09-01",
      "lastUpdated": "2026-10-27T00:00:00.000Z",
      "firstPosted": "2026-10-27T00:00:00.000Z",
      "resultsAvailable": false,
      "sourceRegistries": [
        "clinicaltrials_gov"
      ],
      "sourceUrls": [
        "https://clinicaltrials.gov/study/NCT07897409"
      ]
    },
    "identifiers": [
      {
        "idType": "nct",
        "idValue": "NCT07897409",
        "declaredBy": "clinicaltrials_gov"
      }
    ],
    "sourceRecords": [
      {
        "registry": "clinicaltrials_gov",
        "registryName": "ClinicalTrials.gov",
        "license": "public-domain",
        "sourceId": "NCT07897409",
        "sourceUrl": "https://clinicaltrials.gov/study/NCT07897409",
        "sourceStatus": "NOT_YET_RECRUITING",
        "retrievedAt": "2026-10-28T04:32:18.986Z",
        "payloadSha256": "2f6d2499953c87cefa36e65d0e6b09f8581da1f17e53813640a7006346cd88ff",
        "piiRedacted": true
      }
    ],
    "citation": {
      "canonicalId": "NCT07897409",
      "sources": [
        {
          "registry": "clinicaltrials_gov",
          "registryName": "ClinicalTrials.gov",
          "license": "public-domain",
          "sourceId": "NCT07897409",
          "verifyAt": "https://clinicaltrials.gov/study/NCT07897409",
          "retrievedAt": "2026-10-28T04:32:18.986Z",
          "payloadSha256": "2f6d2499953c87cefa36e65d0e6b09f8581da1f17e53813640a7006346cd88ff",
          "text": "ClinicalTrials.gov, record NCT07897409 (https://clinicaltrials.gov/study/NCT07897409), retrieved 2026-10-28, licence: public-domain."
        }
      ],
      "crossRegistry": false,
      "dedupMethod": "exact cross-registry identifier matching; probabilistic = review only",
      "text": "Trial NCT07897409, registered in ClinicalTrials.gov, retrieved 2026-10-28. Verify at the source URLs listed; each retrieval is checksummed.",
      "note": "Only one registry is known to hold this trial. Absence from the others is not evidence it was not registered there."
    },
    "provenanceNote": "Personal contact fields (names, emails, phone numbers, addresses) are stripped from every stored payload. No participant-level data is collected or served."
  },
  "_meta": {
    "api": "The Last Economy Wire: World Trials API",
    "version": "1.0",
    "schemaVersion": "1",
    "correlationId": "req_OXnH9Z7WpY6G",
    "generatedAt": "2026-10-30T22:25:00.171Z",
    "documentation": "https://negativeresistance.com/embed",
    "license": "Free for any use. Attribution appreciated.",
    "degraded": false,
    "provenance": {
      "sources": [
        "clinicaltrials_gov"
      ],
      "attribution": {
        "clinicaltrials_gov": "ClinicalTrials.gov: licence: public-domain, https://clinicaltrials.gov/data-api/api-docs"
      },
      "dedupMethod": "exact cross-registry identifier matching; probabilistic = review only",
      "limitations": [],
      "provenanceEndpoint": "/api/v1/sources"
    },
    "freshness": {
      "newestEvidenceAt": null,
      "lastSyncedAt": {
        "clinicaltrials_gov": "2026-10-28T04:33:30.663Z"
      },
      "degradedSources": [],
      "worldwide": false,
      "maxAgeHours": 65.9,
      "fromCache": false
    },
    "links": {
      "discovery": "https://negativeresistance.com/api/v1",
      "openapi": "https://negativeresistance.com/api/v1/openapi.json",
      "mcp": "https://negativeresistance.com/api/v1/mcp",
      "agentCard": "https://negativeresistance.com/.well-known/agent.json",
      "aiPlugin": "https://negativeresistance.com/.well-known/ai-plugin.json",
      "sdk": "https://negativeresistance.com/api/v1/sdk",
      "status": "https://negativeresistance.com/api/v1/status",
      "provenance": "https://negativeresistance.com/api/v1/sources",
      "contract": "https://negativeresistance.com/api/v1/contract",
      "curriculum": "https://negativeresistance.com/api/v1/curriculum",
      "graph": "https://negativeresistance.com/api/v1/graph",
      "openQuestions": "https://negativeresistance.com/api/v1/open-questions",
      "scoreboard": "https://negativeresistance.com/api/v1/scoreboard",
      "findings": "https://negativeresistance.com/api/v1/findings",
      "claims": "https://negativeresistance.com/api/v1/claims",
      "threads": "https://negativeresistance.com/api/v1/threads",
      "assignment": "https://negativeresistance.com/api/v1/assignment",
      "changes": "https://negativeresistance.com/api/v1/changes",
      "hello": "https://negativeresistance.com/api/v1/hello",
      "errors": "https://negativeresistance.com/api/v1/errors",
      "webhooks": "https://negativeresistance.com/api/v1/webhooks",
      "a2a": "https://negativeresistance.com/api/v1/a2a",
      "deadEnds": "https://negativeresistance.com/api/v1/dead-ends",
      "decompositions": "https://negativeresistance.com/api/v1/decompositions",
      "rungs": "https://negativeresistance.com/api/v1/rungs",
      "methods": "https://negativeresistance.com/api/v1/methods",
      "reality": "https://negativeresistance.com/api/v1/reality",
      "council": "https://negativeresistance.com/api/v1/council",
      "calibration": "https://negativeresistance.com/api/v1/calibration",
      "freshness": "https://negativeresistance.com/api/v1/freshness",
      "mission": "https://negativeresistance.com/api/v1/mission",
      "twin": "https://negativeresistance.com/api/v1/twin",
      "twinExperiment": "https://negativeresistance.com/api/v1/twin/experiment",
      "betaCell": "https://negativeresistance.com/api/v1/twin/beta-cell",
      "patientModel": "https://negativeresistance.com/api/v1/twin/patient-model",
      "agentCardCanonical": "https://negativeresistance.com/.well-known/agent-card.json",
      "collaborate": "https://negativeresistance.com/collaborate",
      "manifesto": "https://negativeresistance.com/about",
      "documentation": "https://negativeresistance.com/embed",
      "connect": "https://negativeresistance.com/connect",
      "llmsTxt": "https://negativeresistance.com/llms.txt",
      "llmsFullTxt": "https://negativeresistance.com/llms-full.txt"
    },
    "disclaimer": "Research data from public registries and literature; not medical advice."
  }
}